Cargando…

Effect of tolvaptan on acute heart failure with hyponatremia – A randomized, double blind, controlled clinical trial

OBJECTIVES: To assess the efficacy of tolvaptan in acute heart failure with hyponatremia using a randomized double-blinded placebo-controlled study design. BACKGROUND: Tolvaptan is a selective vasopressin receptor 2 antagonist. There are no published clinical trials on the utility of tolvaptan in ac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shanmugam, Elangovan, Doss, C.R. Madhu Prabhu, George, Melvin, Jena, Amrita, Rajaram, Muthukumar, Ramaraj, Balaji, Anjaneyan, Karthik, Kanagesh, B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4824334/ https://www.ncbi.nlm.nih.gov/pubmed/27056648 http://dx.doi.org/10.1016/j.ihj.2015.07.006

Ejemplares similares

Tolvaptan, hyponatremia, and heart failure
por: Zmily, Hammam D, et al.
Publicado: (2011)

Tolvaptan and its potential in the treatment of hyponatremia
por: Dixon, Megan B, et al.
Publicado: (2008)

Clinical utility of tolvaptan in the management of hyponatremia in heart failure patients
por: Nodari, Savina, et al.
Publicado: (2010)

Riociguat: Something new in pulmonary hypertension therapeutics?
por: Shanmugam, Elangovan, et al.
Publicado: (2015)

GDF 15 - A Novel Biomarker in the Offing for Heart Failure
por: George, Melvin, et al.
Publicado: (2016)

Renoprotection by long‐term low‐dose tolvaptan in patients with heart failure and hyponatremia
por: Oka, Tatsufumi, et al.
Publicado: (2021)

Tolvaptan in the Treatment of Acute Hyponatremia Associated with Acute Kidney Injury
por: Gopinath, Shilpa, et al.
Publicado: (2013)

Tolvaptan for hyponatremia with preserved sodium pool in critically ill patients
por: Umbrello, Michele, et al.
Publicado: (2016)

Tolvaptan treatment improves survival of cirrhotic patients with ascites and hyponatremia
por: Wang, Shuzhen, et al.
Publicado: (2018)

Management of hyponatremia associated with acute porphyria—proposal for the use of tolvaptan
por: Solares, Isabel, et al.
Publicado: (2020)

Edematous Hyponatremia Treated with Tolvaptan in a Patient with Amyotrophic Lateral Sclerosis
por: Kim, Gheun-Ho
Publicado: (2017)

Unpredictable Nature of Tolvaptan in Treatment of Hypervolemic Hyponatremia: Case Review on Role of Vaptans
por: Malhotra, Ishan, et al.
Publicado: (2014)

Effect of tolvaptan on hyponatremia in a dog with syndrome of inappropriate secretion of antidiuretic hormone
por: YAMAMOTO, Hiroka, et al.
Publicado: (2023)

Tolvaptan vs. furosemide‐based diuretic regimens in patients hospitalized for heart failure with hyponatremia (AQUA‐AHF)
por: Ng, Tien M.H., et al.
Publicado: (2020)

SIADH-related hyponatremia in hospital day care units: clinical experience and management with tolvaptan
por: De las Peñas, Ramón, et al.
Publicado: (2015)

Safety and Efficacy of Tolvaptan in Korean Patients with Hyponatremia Caused by the Syndrome of Inappropriate Antidiuretic Hormone
por: Han, Sang Woong, et al.
Publicado: (2018)

Using Tolvaptan to Treat Hyponatremia: Results from a Post-authorization Pharmacovigilance Study
por: Estilo, Alvin, et al.
Publicado: (2021)

Low-Dose Tolvaptan for the Treatment of Dilutional Hyponatremia in Cirrhosis: A Case Report and Literature Review
por: Shen, Guo, et al.
Publicado: (2014)

Role of tolvaptan in the management of hyponatremia in patients with lung and other cancers: current data and future perspectives
por: Thajudeen, Bijin, et al.
Publicado: (2016)

Association between the Serum Sodium Levels and the Response to Tolvaptan in Liver Cirrhosis Patients with Ascites and Hyponatremia
por: Hayashi, Manabu, et al.
Publicado: (2018)

Tolvaptan Versus Fluid Restriction in the Treatment of Hyponatremia Resulting from SIADH Following Pituitary Surgery
por: Kleindienst, Andrea, et al.
Publicado: (2020)

Hyponatremia in Cirrhosis and End-Stage Liver Disease: Treatment with the Vasopressin V(2)-Receptor Antagonist Tolvaptan
por: Gaglio, Paul, et al.
Publicado: (2012)

Bortezomib-induced hyponatremia: tolvaptan therapy permits continuation of lenalidomide, bortezomib and dexamethasone therapy in relapsed myeloma
por: O’Connor-Byrne, N., et al.
Publicado: (2019)

Tolvaptan in the Management of Acute Euvolemic Hyponatremia After Transsphenoidal Surgery: A Retrospective Single-Center Analysis
por: Indirli, Rita, et al.
Publicado: (2021)

A rapid and efficient way to manage hyponatremia in patients with SIADH and small cell lung cancer: treatment with tolvaptan
por: Petereit, Claudia, et al.
Publicado: (2013)

Tolvaptan Treatment in Children with Chronic Hyponatremia due to Inappropriate Antidiuretic Hormone Secretion: A Report of Three Cases
por: Tuli, Gerdi, et al.
Publicado: (2017)

Tolvaptan
por: Rangarajan, Bharath, et al.
Publicado: (2014)

A prospective study to compare the clinical efficacy of Tolvaptan with 3% hypertonic saline solution in hospitalized patients having hyponatremia
por: Vilapurathu, Jobin Kunjumon, et al.
Publicado: (2014)

Treatment of Hyponatremia with Tolvaptan in a Patient after Neurosurgical Treatment of a Pituitary Tumor: Case Report and Review of Literature
por: Ichimura, Shinya, et al.
Publicado: (2015)

Efficacy of vaptans for correction of postoperative hyponatremia: A comparison between single intravenous bolus conivaptan vs oral tolvaptan
por: Rajan, Sunil, et al.
Publicado: (2018)

The role of tolvaptan in managing hyponatremia in small cell lung cancer patients with SIADH: a retrospective study of 23 cases
por: Ren, Peng, et al.
Publicado: (2021)

Low-dose tolvaptan PK/PD: comparison of patients with hyponatremia due to syndrome of inappropriate antidiuretic hormone secretion to healthy adults
por: Shoaf, Susan E., et al.
Publicado: (2017)

Long-term low-dose tolvaptan treatment in hospitalized male patients aged >90 years with hyponatremia: Report on safety and effectiveness
por: Liu, Yu-hong, et al.
Publicado: (2017)

Efficacy and safety of oral tolvaptan in patients undergoing hemodialysis: a Phase 2, double-blind, randomized, placebo-controlled trial
por: Ogata, Hiroaki, et al.
Publicado: (2020)

Hemodynamic and Hormonal Effects of Tolvaptan for Heart Failure
por: Kiuchi, Shunsuke, et al.
Publicado: (2018)

Tolvaptan- and Tolvaptan-Metabolite-Responsive T Cells in Patients with Drug-Induced Liver Injury
por: Gibson, Andrew, et al.
Publicado: (2020)

Tolvaptan use in cancer patients with hyponatremia due to the syndrome of inappropriate antidiuretic hormone: a post hoc analysis of the SALT‐1 and SALT‐2 trials
por: Gralla, Richard J., et al.
Publicado: (2017)

Tolvaptan: A Novel Diuretic in Heart Failure Management
por: Zulkifli Amin, Hilman, et al.
Publicado: (2016)

Long-Term Tolvaptan Treatment in Refractory Heart Failure
por: Imamura, Teruhiko, et al.
Publicado: (2019)

Tolvaptan for the Treatment of Refractory Ascites
por: Kurosaki, Masayuki, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_128v3vd1vocf5489ps60kmjpt4